JAMA 303:14101418 Pratley RE, Nauck M, Bailey T et al (2010) Liraglutide vs sitagliptin for patients with type 2 diabetes who did not have adequate glycaemic control with metformin: a 26-week, randomised, parallel-group, open-label trial
Los investigadores ya no se limitan al mbito del fitness, sino que estn explorando cmo puede contribuir a mantener los niveles de energa, la funcin fsica, la recuperacin y la salud mitocondrial a lo largo del tiempo
Conclusion This updated meta-analysis demonstrates that the use of semaglutide is not associated with an increased risk of acute pancreatitis compared to placebo
Oh KW, Lee WY, Rhee EJ, Baek KH, Yoon KH, Kang M, et al
Summary: Injection site selection matters for GLP-1 medications to prevent tissue damage and ensure comfort, though all approved sites deliver equivalent medication exposure
Www.orthoinfo.org